Show notes
How does extravasation affect nuclear medicine? In what ways does vascular access impact nuclear medicine? The ISAVE That Podcast welcomes Ron Lattanze, the CEO of Lucerno Dynamics, to the show to answer these questions and more through data and further research ahead of the closing of a public comment period for a petition he spearheaded to the Nuclear Regulatory Commission.0:00 AVA President Lori Kaczmarek, AVA Director of Clinical Education Judy Thompson and AVA Director of Communications Eric Seger kick off Episode 81:23 Lucerno Dynamics CEO Ron Lattanze Joins the Show2:00 Extravasation in Nuclear Medicine7:30 How Nuclear Medicine Impacts Vascular Access10:00 How Do We Address This Issue?13:31 A Deeper Explanation for Extravasation in Nuclear Medicine16:55 Extravasation in Nuclear Medicine is Preventable28:55 Public Comment at the Nuclear Regulatory Commission35:12 Comments Due by November 30Support the show (https://www.avainfo.org/donations/donate.asp?id=12834)
